Cabaletta Bio
IPOCabaletta Bio, Inc.
Public · Philadelphia, PA, United States
- Headquarters
- Philadelphia, PA
- Business Model
- B2B
- Website
- cabalettabio.com
- Last Round
- Series BJan 2019
- Rounds
- 2
- Type
- Public
About
Cabaletta Bio is a clinical-stage biotechnology company developing targeted CAAR T cell therapies to cure autoimmune diseases.
Summary
Cabaletta Bio is a Biotech company based in Philadelphia, PA, United States. Its most recent funding was a Series B round in Jan 2019. Investors include Deerfield Management, Adage Capital and Boxer Capital.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2019
Sign up to see all 3 rounds
Series A through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cabaletta-bio"><img src="https://indexed.vc/api/badge/company/cabaletta-bio" alt="Cabaletta Bio on Indexed.vc" width="260" height="76" /></a>